Enming Xing

449 total citations
19 papers, 272 citations indexed

About

Enming Xing is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Enming Xing has authored 19 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Infectious Diseases. Recurrent topics in Enming Xing's work include Prostate Cancer Treatment and Research (3 papers), Click Chemistry and Applications (2 papers) and DNA Repair Mechanisms (2 papers). Enming Xing is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Click Chemistry and Applications (2 papers) and DNA Repair Mechanisms (2 papers). Enming Xing collaborates with scholars based in United States, China and Hong Kong. Enming Xing's co-authors include Pui‐Kai Li, Ross C. Larue, Kenneth K.W. To, Amit Sharma, Adam D. Kenney, Jiànróng Lǐ, Yuexiu Zhang, Jacob S. Yount, Kunyu Yang and Zhe‐Sheng Chen and has published in prestigious journals such as Advanced Materials, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Enming Xing

18 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enming Xing United States 9 140 49 43 26 26 19 272
Emeline Cros‐Perrial France 13 211 1.5× 27 0.6× 75 1.7× 43 1.7× 13 0.5× 33 371
Philippe Roby United States 8 244 1.7× 24 0.5× 55 1.3× 39 1.5× 28 1.1× 14 339
Shravan Morla United States 9 214 1.5× 55 1.1× 44 1.0× 94 3.6× 9 0.3× 14 390
Michael V. Gormally United States 9 293 2.1× 24 0.5× 68 1.6× 20 0.8× 7 0.3× 18 418
Yukiko Hiraiwa Japan 10 162 1.2× 36 0.7× 60 1.4× 53 2.0× 8 0.3× 18 375
Zeng Wang China 11 158 1.1× 19 0.4× 100 2.3× 80 3.1× 22 0.8× 31 433
William P. Bozza United States 12 264 1.9× 51 1.0× 98 2.3× 15 0.6× 6 0.2× 15 441
Cheng-Chung Huang Taiwan 10 106 0.8× 45 0.9× 67 1.6× 6 0.2× 11 0.4× 19 381
Chetna Sharon United States 11 165 1.2× 164 3.3× 41 1.0× 31 1.2× 10 0.4× 16 382
Wen Zhou China 11 429 3.1× 34 0.7× 24 0.6× 63 2.4× 12 0.5× 37 544

Countries citing papers authored by Enming Xing

Since Specialization
Citations

This map shows the geographic impact of Enming Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enming Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enming Xing more than expected).

Fields of papers citing papers by Enming Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enming Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enming Xing. The network helps show where Enming Xing may publish in the future.

Co-authorship network of co-authors of Enming Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Enming Xing. A scholar is included among the top collaborators of Enming Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enming Xing. Enming Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Shen, et al.. (2025). TopMT-GAN: a 3D topology-driven generative model for efficient and diverse structure-based ligand design. Chemical Science. 16(6). 2796–2809. 3 indexed citations
2.
Eldesouky, Hassan E., et al.. (2025). Netupitant Exhibits Potent Activity on Mycobacterium tuberculosis Persisters. ACS Infectious Diseases. 11(8). 2265–2275.
3.
Zhang, Zhaojun, Enming Xing, Minghui Song, et al.. (2025). Rapid identification of pathogenic bacteria from clinical positive blood cultures via virus-like magnetic bead enrichment and MALDI-TOF MS profiling. The Analyst. 150(5). 827–840. 1 indexed citations
4.
Ning, Shu, Enming Xing, Wei Lou, et al.. (2024). LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy. Cancer Research. 84(21). 3617–3628. 4 indexed citations
5.
Xing, Enming, Anees M. Dauki, Hanna S. Radomska, et al.. (2023). SAT021 Development Of Niclosamide Analogs For Treatment Of Androgen Receptor Positive Hepatocellular Carcinoma. Journal of the Endocrine Society. 7(Supplement_1). 1 indexed citations
6.
Yang, Jianqi, et al.. (2023). Construction of Prognostic Nomogram in Patients with N3-Stage Nasopharyngeal Carcinoma. ORL. 85(4). 195–207. 2 indexed citations
7.
To, Kenneth K.W., Enming Xing, Ross C. Larue, & Pui‐Kai Li. (2023). BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications. Molecules. 28(7). 3043–3043. 56 indexed citations
8.
9.
Kong, Xiaotian, Enming Xing, Sijin Wu, et al.. (2022). Computational modeling studies reveal the origin of the binding preference of 3‐(3,4‐di hydroisoquinolin‐2(1H)‐ylsulfonyl)benzoic acids for AKR1C3 over its isoforms. Protein Science. 31(12). e4499–e4499. 4 indexed citations
10.
Xing, Enming, Moray J. Campbell, Pui‐Kai Li, et al.. (2022). Constitutively Active Androgen Receptor in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 23(22). 13768–13768. 11 indexed citations
11.
Li, Jia, Leli Zeng, Zheng Wang, et al.. (2021). Cycloruthenated Self‐Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers. Advanced Materials. 34(1). e2100245–e2100245. 46 indexed citations
12.
Xing, Enming, et al.. (2021). Development of Murine Leukemia Virus Integrase-Derived Peptides That Bind Brd4 Extra-Terminal Domain as Candidates for Suppression of Acute Myeloid Leukemia. ACS Pharmacology & Translational Science. 4(5). 1628–1638. 7 indexed citations
13.
Xing, Enming, et al.. (2021). Mechanistic Insights into the Allosteric Inhibition of Androgen Receptors by Binding Function 3 Antagonists from an Integrated Molecular Modeling Study. Journal of Chemical Information and Modeling. 61(7). 3477–3494. 6 indexed citations
14.
Larue, Ross C., Enming Xing, Adam D. Kenney, et al.. (2020). Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2. Bioconjugate Chemistry. 32(1). 215–223. 66 indexed citations
15.
Sheng, Ren, Yanchun Zhang, Enming Xing, et al.. (2018). Discovery of novel selective GPR120 agonists with potent anti-diabetic activity by hybrid design. Bioorganic & Medicinal Chemistry Letters. 28(15). 2599–2604. 14 indexed citations
16.
Tang, Yuanyuan, Enming Xing, Fei Wang, et al.. (2018). Size-Dependent Effect of Cu2O Nanocubes in Electrochemical and Photocatalytic Properties. Journal of Nanoscience and Nanotechnology. 18(12). 8282–8288. 11 indexed citations
17.
Shi, Wei, Yuan Yin, Enming Xing, et al.. (2013). Optimization of parameters for preparation of docetaxel-loaded PLGA nanoparticles by nanoprecipitation method. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(5). 754–758. 16 indexed citations
18.
Zhou, Hongxia, Xiaoqian Mu, Jing Chen, et al.. (2013). RNAi silencing targeting RNF8 enhances radiosensitivity of a non-small cell lung cancer cell line A549. International Journal of Radiation Biology. 89(9). 708–715. 12 indexed citations
19.
Li, Yuhui, Hongxia Zhou, Enming Xing, et al.. (2011). Contribution of decreased expression of Ku70 to enhanced radiosensitivity by sodium butyrate in glioblastoma cell line (U251). Journal of Huazhong University of Science and Technology [Medical Sciences]. 31(3). 359–364. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emeline Cros‐Perrial Breakdown of academic impact, for papers by Philippe Roby Breakdown of academic impact, for papers by Shravan Morla Breakdown of academic impact, for papers by Michael V. Gormally Breakdown of academic impact, for papers by Yukiko Hiraiwa Breakdown of academic impact, for papers by Zeng Wang Breakdown of academic impact, for papers by William P. Bozza Breakdown of academic impact, for papers by Cheng-Chung Huang Breakdown of academic impact, for papers by Chetna Sharon Breakdown of academic impact, for papers by Wen Zhou
Rankless by CCL
2026